MiR-200c suppresses TGF-beta signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer
- Resource Type
- Journal
- Source
INTERNATIONAL JOURNAL OF CANCER ; SEP 15 2014, 135 6, p1356-p1368, 13p.- Subject
- Language
- English
- ISSN
- 10970215